AOD-9604 acts on adipocyte lipolysis pathways through beta-3 adrenergic receptor signalling, with effects measured at the fat cell level
To obtain BPC-157 legally and safely, it must be prescribed by a licensed medical provider after an evaluation and dispensed by a compounding pharmacy
It also promotes angiogenesis, or the formation of new blood vessels, allowing for increased oxygenation to the tissues
With its multifaceted mechanisms of action and growing body of scientific evidence, this remarkable peptide offers hope for improved treatment options across various medical conditions
Some patients benefit from longer initial cycles of 8-10 weeks, particularly those with severe symptoms or significant inflammatory markers
Not intended for diagnostic, therapeutic, or clinical applications